AVE5530
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AVE5530, covering 2008-12-16 to 2016-05-16. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia [Phase 3]